Top 32 Jounce Therapeutics investors
The most complete profiles first. Showing 32 of 32.
Annie MitsakVerified
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Brett ZbarVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 68 more
Verified email available
Christoph LengauerVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Craig MuirVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Dennis RyanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Dorothy MargolskeeVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Eli CasdinVerified
Venture Capital, Founder, Micro VC · United States
SeedHealth CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 76 more
Verified email available
Matt TaylorVerified
Venture Capital, Advisor, Private Equity Firm · United Kingdom
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Rhonda KaufmanVerified
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedLife SciencePortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Verified email available
Robert TepperVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
AnneVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Noreen RizviVerified
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Verified email available
Paulina HillVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Verified email available
Rob FaulknerVerified
Hedge Fund, Venture Capital, Private Equity Firm · United States
Health CareHospitalsGeneticsWomen FoundedPortfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more
Contact details available
Abbie Celniker
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 54 more
Contact details available
Cary Pfeffer
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Francesco Draetta
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
George Xu
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Katie Kerfoot
Venture Capital, Investor · United States
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Luke Bagaason, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Mark Levin
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceEducationPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Michelle Doig
Venture Capital, Investor · Canada
SeedHealth CareGeneticsWomen FoundedLife SciencePortfolio: FoRx Therapeutics, Santaris Pharma, Spruce Biosciences, Attenua and 70 more
Contact details available
Neil Exter
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Richard Lau, CFA
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareHospitalsWomen FoundedInvestment ManagementPortfolio: AveXis, Remix Therapeutics, Karyopharm Therapeutics, Olema Oncology and 66 more
Contact details available
Thomas Lips
Venture Capital, Private Equity Firm, Investor · Switzerland
SeedHealth CareWomen FoundedLife ScienceInformation Technology (IT)Portfolio: Black Diamond Therapeutics, Blueprint Medicines, TRACON Pharmaceuticals, Jounce Therapeutics and 30 more
Contact details available
Adeline Oursler
Micro VC · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more
Contact details available
Cody Tranbarger
Micro VC · United States
Health CareGeneticsWellnessWomen FoundedPortfolio: Goldfinch Biopharma, Notch Therapeutics, Magenta Therapeutics, Syros Pharmaceuticals and 75 more
Contact details available
Gerard van Hamel Platerink
Hedge Fund, Venture Capital, Private Equity Firm · United States
Health CareGeneticsWomen FoundedLife SciencePortfolio: Lifesprout, Blueprint Medicines, OncoResponse, CorVent Medical and 73 more
Contact details available
Kelly Moynihan
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Walter Kowtoniuk
Venture Capital, Private Equity Firm · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
William Motley
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Goldfinch Biopharma, Blueprint Medicines, Magenta Therapeutics, Larimar Therapeutics and 52 more
Contact details available
Jason FullerVerified
Venture Capital, Angel/Individual, Investment Partner · United States
Series BHealth CareInvestment ManagementInformation Technology (IT)Consumer HealthPortfolio: Jounce Therapeutics
Verified email available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Jounce Therapeutics investors are on Angel Roster?
Angel Roster lists 32 Jounce Therapeutics investors. 14 of them (44%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (30), Private Equity Firms (16) and Micro VC Firms (3). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Jounce Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (21) and Series B (1).
Where are Jounce Therapeutics investors based?
Most are based in the United States (29), the United Kingdom (1) and Canada (1).
Which companies have Jounce Therapeutics investors backed?
The most-backed portfolio companies among them are Relay Therapeutics (22), Fulcrum Therapeutics (22), Decibel Therapeutics (22), Insitro (22) and Maze Therapeutics (22).
How do I contact Jounce Therapeutics investors?
Create a free Angel Roster account to search and filter all 32, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.